EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation

Vasyl Pastukh iD, Jianying Zhang iD, Peter G Alexander iD, Satyaj Bhargava iD, Arshia Shams iD, Celina Zhao iD, MaCalus V Hogan iD, James H-C Wang iD

Journal of Orthopaedic Research · 2026-07 · 44 (7)

DOI: 10.1002/jor.70246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Research, online erschienen am 04.07.2026. Verfasst von Vasyl Pastukh und 7 weiteren Autor:innen. Beteiligte Einrichtung: MechanoBiology Laboratory, Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pi…. Hauptthemen laut MEDLINE: Metformin, AMP-Activated Protein Kinases, Fracture Healing, Femoral Fractures. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Technology Enterprise Consortium, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Femoral shaft fractures cause prolonged disability, and therapies that accelerate bone repair remain limited. Repurposing clinically approved drugs that target biological bottlenecks in healing is a promising strategy. This study investigated whether systemic metformin administration, an anti‐diabetic medication with known metabolic regulatory effects, enhances fracture repair in a rat open femoral shaft fracture model. Histological, immunofluorescent, micro‐CT, and biomechanical analyses were performed at 6 weeks post‐injury comparing metformin‐treated and vehicle‐treated animals. Metformin markedly accelerated callus maturation, evidenced by earlier hyaline cartilage ossification, increased collagen I deposition and fiber organization, and reduced collagen II and III expression compared with controls. Micro‐CT analysis demonstrated increased tissue mineral density, trabecular thickness, and bone volume fraction along with reduced connectivity density, indicating more advanced structural consolidation of the callus. Although biomechanical parameters were not significantly different at intermediate time point, ultimate load and stiffness trended higher in metformin‐treated animals, consistent with structural advancement. Mechanistically, metformin increased p‐AMPK expression, elevated mitochondrial markers (NDUFB8, TFAM), and reduced extracellular HMGB1 release, suggesting enhanced metabolic capacity and attenuated inflammatory stress during repair. Importantly, metformin's effects were most pronounced during the cartilage‐to‐bone transition phase, supporting a role for metabolic activation in promoting endochondral ossification. Together, these findings demonstrate that systemic metformin administration promotes earlier structural consolidation of the fracture callus through coordinated metabolic and inflammatory modulation, supporting the potential repurposing of this safe and inexpensive drug as an adjunct strategy to enhance bone repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminAMP-Activated Protein KinasesFracture HealingFemoral FracturesBony CallusDrug RepositioningHypoglycemic AgentsAnimalsMaleRatsRats, Sprague-Dawley

Stichwörter der Autor:innen

AMPK signalingdrug repurposingendochondral ossificationfracture repairmitochondrial biogenesis

Substanzen

MetforminAMP-Activated Protein KinasesHypoglycemic Agents

Autor:innen und Institutionen

  • MechanoBiology Laboratory, Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Joint Tissue Development and Engineering Laboratory, Bethel Musculoskeletal Research Center, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Vasyl Pastukh, Jianying Zhang, Peter G Alexander, Satyaj Bhargava, Arshia Shams, Celina Zhao, MaCalus V Hogan, James H-C Wang

Förderung

  • Medical Technology Enterprise Consortium
  • U.S. Department of Defense

Zitieren

APA

Pastukh, V., Zhang, J., Alexander, P. G., Bhargava, S., Shams, A., Zhao, C., Hogan, M. V., & Wang, J. H. (2026). Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation. Journal of Orthopaedic Research, 44(7). https://doi.org/10.1002/jor.70246

Vancouver

Pastukh V, Zhang J, Alexander PG, Bhargava S, Shams A, Zhao C, et al. Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation. Journal of Orthopaedic Research. 2026;44(7). doi:10.1002/jor.70246

BibTeX
@article{Pastukh2026,
  author = {Pastukh, Vasyl and Zhang, Jianying and Alexander, Peter G and Bhargava, Satyaj and Shams, Arshia and Zhao, Celina and Hogan, MaCalus V and Wang, James H-C},
  title = {Repurposing Metformin to Promote Fracture Callus Maturation via AMPK‐Driven Metabolic Activation},
  journal = {Journal of Orthopaedic Research},
  year = {2026},
  volume = {44},
  number = {7},
  doi = {10.1002/jor.70246}
}
Kostenlos starten →